cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients

Oxidative Medicine and Cellular Longevity

Volumn 2, Issue 5, 2009, Pages 317-321

  Isoni, Camila Armond ^a   Borges, Érica Abreu ^a   Veloso, Clara Araújo ^a   Mattos, Rafael Teixeira ^a   Chaves, Miriam Martins ^b   Nogueira Machado, José Augusto ^a  

^a Hospital Santa Casa de Belo Horizonte   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

cAMP; Diabetes; IL 6; Peripheral blood mononuclear cells; ROS

Indexed keywords

CYCLIC AMP; INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC PATIENT; HUMAN; HUMAN CELL; HYPERGLYCEMIA; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT;

ADULT; AGED; CYCLIC AMP; DIABETES MELLITUS, TYPE 2; HUMANS; INTERFERONS; INTERLEUKIN-4; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; REACTIVE OXYGEN SPECIES;

EID: 77953428460     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.2.5.9657     Document Type: Article

References (30)

1. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27:813-23.
2. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003; 26:1589-96.
3. Thomas E, Lin YA, Dagher Z, Saha A, Luo Z, Ido Y, et al. Hyperglycemia and insulin resistance: Possible mechanisms. Ann NY Acad Sci 2002; 967:43-51.
4. Srivastava AK. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes. Int J Mol Med 2002; 9:85-9.
5. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998; 17:25596-606.
6. Benbernou N, Esnault S, Shin HCK, Fekkar H, Guenounou M. Differential regulation of IFN?, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 1997; 91:361-8.
7. Bergamaschi A, Corsi M, Garnier MJ. Synergistic effects of cAMP-dependent signalling pathway and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells. Cell Signal 2006; 18:1679-84.
8. Fasshauer M, Klein J, Lossner U, Paschke R. Interleukin (IL)-6 mRNA expression in stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone and IL-6 in 3T3-L1 adipocytes. Horm Metab Res 2003; 35:147-52.
9. Jakob T, Huspith BN, Latchman YE, Rycroft R, Brostoff J. Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin Exp Immunol 1990; 70:380-4.
10. Izuora KE, Chase HP, Jackson WE, Coll JR, Osberg IM, Gottlieb PA, et al. Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care 2005; 28:714-5.
11. Nishikawa T, Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antiox Redox Signal 2007; 9:343-53.
12. Lo CJ. Upregulation of cyclooxygenase-II gene and PGE2 production of peritoneal macrophages in diabetic rats. J Surg Res 2005; 125:121-7.
13. Nogueira-Machado JA, cols. Modulation of the production of reactive oxygen species (ROS) by cAMPelevating agents in granulocytes from diabetic patients: an Akt/PKB dependent phenomenon. Diabetes Metab 2006; 32:331-5.
14. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 1998; 37:832-7.
15. Mohanty P, Hamouda W, Garg RK, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leukocytes. J Clin Endocrinol Metab 2005; 85:2970-3.
16. Cobbs MH, Goldsmith M. How MAP kinases are regulated. J Biol Chem 1995; 270:1483-6.
17. Treiman R. Regulation of transcription by MAPKinases cascades. Curr Opin Cell Biol 1996; 8:205-15.
18. MAPK and IKK in macrophage; implication in the induction on inducible nitric oxide synthase and interleukin 6 by dibutyryl cAMP. Cellular Signalling 2004; 16:565-75.
19. Ridley SH, Sarsfiel SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ. Interleukin-1-induced rat pancreatic islet nitric oxide synthesis require both the p38 and intracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol 1997; 158:165-73.
20. Larsen CM, Wadt KAW, Juhl LF, Andersen HU, Karlsen AE, Su MSS. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: kinase: regulation of prostaglandin H synthase-2, metalloproteinases and IL-6 at different levels. J Biol Chem 1998; 273:15294-300.
21. Kukidone D, Nishinawa T, Somoda K, Imoto K, Fujisawa K, Yano M, et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biuogenesis in human umbilical vein endothelial cells. Diabetes 2006; 55:120-7.
22. Kelly M, Gauthier MS, Saha AK, Rudeman NB. Activation of AMP-activated protein kinases (AMPK) mby interleukin 6 inskletal muscle: association with changes in cAMP, energy states and endogenous fuel mobilization. Diabetes 2009; (ahead of print).
23. Nogueira-Machado JA, Lima e Silva FC, Medina LO, Costa DC, Chaves MM. Modulation of the reactive oxygen species (ROS) generation mediated by cyclic AMP-elevating agents or interleukin 10 in granulocytes from type 2 diabetic patients (NIDDM): a PKAindependent phenomenon. Diabetes Metab 2003; 29:533-7.
24. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not Th2 lymphokines. J Immunol 1991; 146:108-13.
25. Novak TJ, Rothenberg EV. cAMP inhibits induction of interleukin 2 but not interleukin 4 in T cells. Proc Natl Acad Sci USA 1990; 87:9353-7.
26. Glund S, Deshnmukh A, Long YC, Moller T, Koistinen HA, Caidahl K, et al. IL-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes 2007; 56:1630-7.
27. Tan KS, Nackley AG, Satterfield K, Maixner G, Diatchenko L, Flood PM. Beta(2) adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA and NFkappaBindependent mechanisms. Cell Signal 2007; 19:251-60.
28. Mahomed AG, Theron AJ, Anderson R, Feldman C. Anti-oxidative effects of theophylline on human neutrophils involves cyclic nucleotides and protein kinase A. Inflammation 1998; 22:545-57.
29. Nogueira-Machado JA, Lima e Silva FC, Cunha PE, Costa DC, Chaves MM. Modulation of the production of reactive oxygen species (ROS) by cAMP-elevating agents in granulocytes from diabetic patients: a Akt/ PKB-dependent phenomenon. Diabetes Metab 2006; 32:331-5.
30. Bicalho HMS, Gontijo CM, Nogueira-Machado JA. A simple technique for simultaneous human leukocyte separation. J Immunol Meth 1981; 40:115-6.